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where infection with the CPXV double-
deletion mutant virus correlated with
reduced virus load ten days after infection
and in long-term survival (Byun et al.,
2009). Moreover, the protective effect
was suppressed by depletion of CD8+
T cells (Byun et al., 2009). This synergistic
contribution of CPXV12 and CPXV203 to
in vivo virulence clearly demonstrates
that T cells can play an important role in
host defense against poxvirus infection.
It is therefore somewhat surprising that
CPXV12’s function as a TAP inhibitor is
restricted to a single poxvirus species
and that even within the species CPXV,
it is not ubiquitous. The CPXV12 homo-
logs in strains GRI and GER-91 are highly
conserved through their transmembrane
domain, but diverge in their C-terminal
ER lumenal elements. The Fru¨h laboratory
speculates that the larger protein in strain
GER-91 has properties compatible with it
being an NK cell-inhibitory receptor.
The capacity of CPXV12 and CPXV203
together to promote virulence is impres-
sive, particularly when compared to similar
experiments performed with murine
cytomegalovirus (MCMV). Despite the
well-documented role of CD8 T cells
in eliciting protection against MCMV,
deletion of three genes implicated in sup-
pressing antigen presentation to CD8+
T cells had only a modest effect on viru-
lence in vivo (Gold et al., 2004). Therefore,
CPXV provides a powerful and physiolog-
ically relevant model system to study the
in vivo role of virus-induced MHC class I
downregulation.
Perhaps the irony for the unsuspecting
Jenner was that his vaccine strategy will
have induced the generation of cross-
reactive CTLs that were fortuitously
more effective against the smallpox target
than against the inoculating agent—
something we struggle to achieve with
vaccination today.
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Aging causes enhanced susceptibility to viral infections. Stout-Delgado et al. (2009) report increased IL-17A
production but reduced type I interferon levels in old mice infected by herpes viruses. This imbalance
between proinflammatory and antiviral innate cytokine responses causes immunopathology and compro-
mises virus control, which together lead to death by liver failure.The elderly are more susceptible to path-
ogens, in particular to viral infections.
Influenza or respiratory syncytial virus
(RSV) infections lead to higher mortality
in old people (Thompson et al., 2003).
RSV infection causes approximately
10,000 and influenza A 37,000 yearlydeaths among persons over 64 years old
(Falsey and Walsh, 2005). This dramatic
outcome is a big concern, in particular in
developed countries, where the elderly
represent a growing part of the popula-
tion. Identifying which changes of the
immune responses induced during agingCell Host & Microbe 6, Ncontribute to the enhanced susceptibility
of the elderly to viral infections is needed
to improve health care.
A recent review on the aging of the
immune system pointed out that studies
on adaptive immunity are much more
advanced than those on innate immunityovember 19, 2009 ª2009 Elsevier Inc. 397
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Figure 1. Imbalanced Innate Immune Responses Critically Contribute to Herpes Virus-Induced Death in Old Mice
The work by Stout-Delgado et al., (2009) in the current issue of Cell Host & Microbe consists of a detailed and robust comparative analysis of innate immune
responses between young and old mice in well-defined models of systemic infections by two different herpes viruses, HSV-2 and MCMV. They uncover that aging
causes an imbalance in proinflammatory versus antiviral innate immune responses, in particular an exacerbation of NKT cell IL-17A production in the liver,
contrasting with an impairment in pDC IFN-I production likely originating from the spleen (Zucchini et al., 2008). This leads to an inefficient control of viral repli-
cation and to an increase in neutrophil-mediated immunopathology, ultimately leading to liver failure—with liver injury measured by release of alanine aminotrans-
ferase (ALT)—and death.(Linton and Dorshkind, 2004). With age,
there is a considerable decrease in adap-
tive antiviral cellular immunity. This is
due in part to a substantial reduction in
naive T cell numbers, concomitant with
an increase in memory T cell numbers.
In addition, naive CD4 T lymphocytes in
aged persons have reduced proliferation
and fail to properly differentiate into
effector cells. Antiviral CD8 T cell re-
sponses are delayed in their kinetics and
decreased in their magnitude. Humoral
responses are also compromised, with
lower affinities and lesser amounts of the
antibodies produced. Few data are avail-398 Cell Host & Microbe 6, November 19, 20able regarding the modifications of the
innate immune system with age. In brief,
natural killer (NK) cells are thought to
increase in number with age, but their
cytotoxicity is diminished on a per-cell
basis, monocytes and macrophages pre-
sent alterations in their cytokine pro-
duction, and the numbers of dendritic
cells (DCs) in the epidermis decrease.
However, how these specific modifica-
tions of the innate immune system during
aging affect the overall ability to control
viral infections remains unknown. More
generally, how aging affects innate
immune responses to viral infections has09 ª2009 Elsevier Inc.not been much investigated. In the current
issue of Cell Host & Microbe, Stout-
Delgado et al. (2009) demonstrate that
old mice show dramatically heightened
susceptibility to early death induced by
primary systemic infections with herpes
viruses, pointing to a major role of innate
immune deregulation in this process.
They elegantly exploit this animal model
to unravel a specific mechanism triggered
by productive viral infection, which ulti-
mately contributes to the induction of
hepatocyte necrosis and to death of
infected aged mice from liver failure: the
unbridled activation of a cascade of
Cell Host & Microbe
Previewsinnate immune responses, from high-level
IL-17A production by natural killer T (NKT)
cells to overwhelming neutrophil recruit-
ment and activation in the liver.
The present work demonstrates that old
mice succumb to infections with herpes
simplex virus 2 (HSV-2) or murine cyto-
megalovirus (MCMV) very early, around
day 5, after intravenous infection, before
the peak of activation of adaptive immu-
nity (Stout-Delgado et al., 2009). Under
these experimental conditions, young
mice survive the infections and do not
show significant morbidity. The height-
ened susceptibility of old mice to the
mortality induced by viral infections is
correlated with their production of higher
systemic levels of the proinflammatory
cytokines IL-17A, TNF-a, and IL-6. IL-17A
is demonstrated to be necessary for the
enhanced mortality induced by the infec-
tion in old mice, since in vivo neutralization
of the cytokine protects the animals.
A subset of NKT cells expressing RORgT,
a transcription factor promoting IL-17
production, has been recently described
and shown to secrete IL-17A in response
to synthetic ligands (Michel et al., 2007;
Rachitskaya et al., 2008). Therefore, the
authors investigated RORgT expression
by NKT cells in old mice and the contribu-
tion of these cells to IL-17A production
upon activation by herpes viruses. Old
animals harbored higher numbers of
NKT cells prior to infection with a higher
level of RORgT expression in these cells.
Using multiple independent approaches,
including IL-17A intracellular staining in
NKT cells, IL-17A titration by ELISA in the
supernatant of in vitro HSV-2-stimulated
NKT cells, as well as analyses in mice
genetically engineered to specifically lack
NKT cells, the authors definitively demon-
strated a major contribution of NKT cells to
the production of IL-17A and to the induc-
tion of disease. The authors then further
dissected the mechanisms triggered
downstream of the activation of NKT cells
for IL-17A production and directly contrib-
uting to enhanced morbidity or death.
They demonstrated that IL-17A leads to
neutrophil recruitment and activation in
the liver, which contributes to local tissue
damage and ultimately to liver failure.
Injection of recombinant IL-17A or
adoptive transfer of IL-17A-producingaged NKT cells in young mice does not
abrogate their resistance to disease.
This demonstrates that high systemic
levels of IL-17A are not sufficient to
induce death in infected animals. The
authors have previously reported
a decrease in the production of type I
interferons (IFN-I) in old mice infected
with HSV-2 or MCMV, consecutive to an
impaired activation of the professional
producers of these antiviral cytokines:
the plasmacytoid dendritic cells (pDCs)
(Stout-Delgado et al., 2008). They confirm
this observation here and further show
that a combination of pDC depletion and
of transfer of aged NKT cells in young
mice leads to a significantly greater
morbidity than either treatment alone,
correlated with enhanced viral replication
and with higher systemic levels of IL-17A.
Thus, both high NKT cell activation for IL-
17A production and failure to efficiently
control viral replication, due in part to
impaired pDC functions, are necessary
to induce disease in infected animals,
while neither of these two alterations
alone is sufficient (Figure 1). Other yet
unknown mechanisms contribute to
further aggravate disease to cause death
in old mice, since young mice depleted
of pDCs and transferred with aged NKT
cells ultimately recovered from the infec-
tions, indicating that the treatment they
received was not mimicking all of the
immune defects developing with aging.
This study opens exciting perspectives
for a better understanding of how innate
immunity deregulation may contribute to
the enhanced susceptibility of elderly
humans to viral infections and for the
design of immunotherapeutic strategies
to fight this phenomenon. However, ques-
tions still remain to be answered before
IL-17A neutralization could be considered
as a possible component of health care
for elderly persons suffering from severe
viral infections. In the animal models
used in the present study, failure to
control viral replication is necessary to
cause disease, and liver failure appears
to be the cause of death. Since MCMV
and perhaps HSV-2 directly infect hepa-
tocytes and cause cytopathic effects, it
would be of great interest to evaluate the
impact of viral tropism on disease devel-
opment and on the cause of death. OneCell Host & Microbe 6,may expect that natural infections with
viruses known to replicate in the respira-
tory tract may lead to NKT cell and neutro-
phil activation in the lung, causing respira-
tory failure rather than liver damage,
which may be especially relevant to the
types of life-threatening viral infections
encountered in elderly humans. From
this point of view, it would be important
to investigate the role of NKT cells and
IL-17A in mouse models of intranasal
infections with RSV or the influenza virus,
for example. Human studies could also be
initiated to evaluate the amount of IL-17A
in sera or bronchoalveolar lavages from
healthy or infected aged persons. Both
types of studies would contribute to as-
sessing the validity for human health of
the observations reported here in the
mouse.
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